- Trials with a EudraCT protocol (147)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
147 result(s) found for: Adenoma.
Displaying page 1 of 8.
EudraCT Number: 2006-007036-95 | Sponsor Protocol Number: CSOM230BDE01 | Start Date*: 2008-07-02 | |||||||||||
Sponsor Name:Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie | |||||||||||||
Full Title: Monocenter, double blinded, exploratory, randomized, study investigating the influence of Pasireotide on the hormonal activity of Prolactinomas - proof of concept study | |||||||||||||
Medical condition: Prolactinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001084-27 | Sponsor Protocol Number: APAC | Start Date*: 2006-06-16 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALI GALLIERA | |||||||||||||
Full Title: Phase I/II study of prevention of Colorectal Cancer CRC with Allopurinol in High-Risk Subjects | |||||||||||||
Medical condition: CHEMOPREVENTION OF COLORECTAL CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004885-32 | Sponsor Protocol Number: 2013-004885-32 | Start Date*: 2015-03-03 |
Sponsor Name:Ospedale Valduce | ||
Full Title: The impact of split dosing preparation on adenoma detection rate: a randomized, investigator-blind, controlled trial | ||
Medical condition: Split dose bowel cleansing for colonoscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002877-30 | Sponsor Protocol Number: CSOM230B2212 | Start Date*: 2006-12-22 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: An open label, multicenter, pilot phase II study of SOM230 s.c. in patients with duodeno-pancreatic (neuro) endocrine tumors and different pituitary diseases (Nelsonメs syndrome, non-functioning ad... | |||||||||||||
Medical condition: duodeno-pancreatic (neuro) endocrine tumors and different pituitary diseases (Nelsonメs syndrome, non-functioning adenoma, TSH-adenoma,Gonadotroph adenoma, and PRL-adenoma) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001815-29 | Sponsor Protocol Number: MDL_2011_36557 | Start Date*: 2011-11-11 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: Chemopreventive effects of mesalazine in patients at high risk of recurrent (nonfamilial) colorectal adenomas | |||||||||||||
Medical condition: sporadic colorectal adenomas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001351-40 | Sponsor Protocol Number: MES-CT01 | Start Date*: 2012-05-02 | ||||||||||||||||
Sponsor Name:SOFAR SPA | ||||||||||||||||||
Full Title: ND | ||||||||||||||||||
Medical condition: NA | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004413-15 | Sponsor Protocol Number: CSOM230B2209 | Start Date*: 2006-06-07 | |||||||||||
Sponsor Name:Cedars Sinai Medical Center | |||||||||||||
Full Title: Effectiveness of SOM230 In Treating Non-Functioning Pituitary Adenomas | |||||||||||||
Medical condition: non-functioning pitiutary adenomes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001711-38 | Sponsor Protocol Number: PC CO 201/08 | Start Date*: 2008-12-16 |
Sponsor Name:Photocure ASA | ||
Full Title: An open dose-finding study of oral applied hexaminolevulinate (HAL) imaging in patients with suspicion or high risk of dysplasia or neoplasia in the colon | ||
Medical condition: Patients with suspicion or high risk of neoplasia in the colon | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-012115-18 | Sponsor Protocol Number: IMP13617 | Start Date*: 2010-03-22 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Primovist enhanced MRI for the detection and evaluation of focal liver lesions | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: All benign and malignant focal liver lesions e.g. colorectal liver metastases, HCC, haemangioma, adenoma, cysts, FNH. | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010918-30 | Sponsor Protocol Number: 2377 | Start Date*: 2009-08-11 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Amar Agha, Beaumont Hospital | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Effect of growth hormone replacement on cortisol-to-cortisone interconversion in hypopituitary patients with growth hormone deficiency and the influence of different aetiologies of hypopituitarism. | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: 20 patients with hypopituitarism including growth hormone deficiency will be evaluated both on growth hormone replacement and when they have been off it for a 2 month period. They will have been pr... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: IE (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000693-31 | Sponsor Protocol Number: COLO CP-01 | Start Date*: 2005-06-17 |
Sponsor Name:Colotech A/S | ||
Full Title: An international, multi centre, randomised, parallel group, prospective, double blind, placebo controlled clinical trial evaluating the efficacy and safety of a combination treatment administered o... | ||
Medical condition: Patients who have had removal of polyp in colon or rectum within 3 months. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003983-32 | Sponsor Protocol Number: CB-17-01/06 | Start Date*: 2013-10-02 |
Sponsor Name:Cosmo Technologies Ltd | ||
Full Title: The safety and efficacy of Methylene Blue MMX® modified release tablets administered to subjects undergoing screening or surveillance colonoscopy. | ||
Medical condition: Polyp and adenoma detection during colonoscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) BE (Completed) DE (Completed) NL (Ongoing) LT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005694-23 | Sponsor Protocol Number: CB-17-01/05 | Start Date*: 2011-12-20 | |||||||||||||||||||||
Sponsor Name:COSMO TECHNOLOGIES LTD | |||||||||||||||||||||||
Full Title: Polyp detection rate after single oral dose of methylene blue MMX(R) modified release tablets administered to subjects undergoing outpatients colonoscopy | |||||||||||||||||||||||
Medical condition: patients scheduled for the screening or surveillance colonoscopy and meeting the joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer and the Ameri... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000131-51 | Sponsor Protocol Number: 1921 | Start Date*: 2019-03-07 | ||||||||||||||||
Sponsor Name:Zealand University Hospital | ||||||||||||||||||
Full Title: Preoperative endoscopic treatment with fosfomycin and metronidazole in patients with right-sided colon cancer and colon adenoma: a clinical proof-of-concept intervention study MEFO trial | ||||||||||||||||||
Medical condition: Colon cancer in track 1. Colon adenoma in track 2. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-007348-32 | Sponsor Protocol Number: CSOM230D2203 | Start Date*: 2009-05-06 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An open label, multicenter, single arm study of pasireotide LAR in patients with rare tumors of neuroendocrine origin | |||||||||||||
Medical condition: The following tumors are included: 1. NETs of the pancreas or duodenum: Insulinoma, Gastrinoma, VIPoma, glucagonoma, 2. Pituitary NETs: Thyrotropic-pituitary adenoma (TSH), Gonadotropic adenoma, Pr... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001234-22 | Sponsor Protocol Number: NL52821.018.15 | Start Date*: 2015-07-01 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: A randomized placebo-controlled study in patients with a Gallium-68 DOTATATE PET/CT positive, clinically non-functioning pituitary macroadenoma (NFMA) of the effect of Lanreotide autosolution on Tu... | |||||||||||||
Medical condition: Clinically non-functioning pituitary macroadenoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000051-10 | Sponsor Protocol Number: A091200 | Start Date*: 2008-05-19 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | ||
Full Title: 11C metomidate PET scanning for Conn's syndrome | ||
Medical condition: Primary hyperaldosteronism - Conn's syndrome and bilateral adrenal hyperplasia. Imaging of adrenal lesions using 11C-metomidate PET. Pre-suppression with dexamethasone and/or fludrocortisone to opt... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-002562-12 | Sponsor Protocol Number: ENDOS2019 | Start Date*: 2019-09-09 |
Sponsor Name:HOSPITAL GENERAL DE CATALUNYA | ||
Full Title: PRAGMATIC, COMPARATIVE AND RANDOMIZED CLINICAL TRIAL OF THE NEW SOLUTION OF 1 LITER POLYETHYLENE GLYCOL VERSUS SODIUM PICOSULFATE WITH MAGNESIUM CITRATE IN THE EFFECTIVENESS OF SCREENING AND SURVE... | ||
Medical condition: Screening and surveillance colonoscopy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005568-28 | Sponsor Protocol Number: 2319/2007 | Start Date*: 2007-10-11 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Safety study of rosiglitazone in patients with acromegaly and assessment of biochemical parameters of disease's activity. | |||||||||||||
Medical condition: Acromegaly due to GH-secreting hypophysial adenoma, persistent after surgical adenomectomy, external radiotherapy or medical therapy with analogous of somatostatin. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003770-85 | Sponsor Protocol Number: DKFZ-2019-007 | Start Date*: 2020-08-20 |
Sponsor Name:German Cancer Research Center (DKFZ) | ||
Full Title: Effect of low-dose acetylsalicylic acid on early detection of advanced colorectal neoplasms | ||
Medical condition: Screening for advanced colorectal neoplasms. Male individuals aged 40 to 79 years scheduled for screening colonscopy and no use of acetylsalicylic acid (or other drugs with an effect on the blood ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
